Loading...
Loading...
Among the 3 tracked institutional investors we monitor, GRCE (GRACE THERAPEUTICS INC) is held with a combined value of $3.07M across 766,633 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.48M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings.
Total Institutional Value
$3.07M
Total Shares Held
766,633
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.48M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $1.13M | 0.00% | +87.9% |
| 3 | CITADEL ADVISORS LLC | $457.18K | 0.00% | +133.4% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of GRCE with a position worth $1.48M, representing 0.00% of their portfolio. In total, 3 institutional investors hold GRCE with a combined value of $3.07M.
In the most recent quarter, 1 fund opened a new position in GRCE. Additionally, 2 increased their holdings.
Institutional investors hold $3.07M worth of GRCE stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $1.48M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GRCE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GRCE positions.